Stay updated on Cabozantinib and Nivolumab in Endometrial Cancer Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib and Nivolumab in Endometrial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib and Nivolumab in Endometrial Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    A note was added that PubMed publications are automatically filled from PubMed and may not be about the study, and the revision version was updated from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-25T13:27:49.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Removed the boilerplate notice about potential delays due to a lapse in government funding from the page; core study details, eligibility criteria, locations, and study design remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-18T07:17:59.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    No substantive changes detected; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T21:08:05.000Z thumbnail image
  5. Check
    62 days ago
    Change Detected
    Summary
    Introducing version v3.2.0 and a government-operating-status notice; removing the older v3.1.0 reference.
    Difference
    2%
    Check dated 2025-10-06T05:33:18.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    - Page now shows that results have been submitted and are available. - Revision updated from v3.0.2 to v3.1.0.
    Difference
    0.1%
    Check dated 2025-09-29T03:07:26.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Revision updated to v3.0.2 and Back to Top removed; no core content or critical information is affected.
    Difference
    0.1%
    Check dated 2025-09-14T19:14:05.000Z thumbnail image

Stay in the know with updates to Cabozantinib and Nivolumab in Endometrial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib and Nivolumab in Endometrial Cancer Clinical Trial page.